1Hillered L, Persson L. Neurochemical monitoring of the acutely injured human brain. Scand J Clin Lab Invest, 1999, 229(suppl): 9-18.
2Berger C, Annecke A, Aschoff A, et al. Neurochemical monitoring of fatal middle cerebral artery infarction. Stroke, 1999, 30(2): 460-463.
3Budlock R, Zauner A, Woodward J, et al. Massive persistent release of excitatory amino acids following human occlusive stroke. Stroke, 1995,26(11): 2187-2189.
4Kanthan R, Shuaib A, Griebel R, et al. Intracerebral human microdialysis. In vivo study of an acute focal ischemic model of the human brain. Stroke, 1995, 26(5): 870-873.
5Persson L, Valtysson J, Enblad P, et al. Neurochemical monitoring using intracerebral microdialysis in patients with subarachnoid hemorrhage. J Neurosurg, 1996, 84(4): 606-616.
6Enb lad P, Valtysson J, Andersson J, et al. Simultaneous intracerebral microdialysis and positron emission tomography in the detection of ischemia in patients with subarachnoid hemorrhage. J Cereb Blood Flow Metab, 1996, 16(4): 637-644.
7Langemann H, Mendelowitsch A, Landolt H, et al. Experimental and clinical monitoring of glucose by microdialysis. Clin Neurol Neurosurg,1995, 97(2): 149-155.
8Fujisawa H, Landolt H, Bullock R. Patterns of increased glucose use following extracellular infusion of glutamate: an autoradiographic study.J Neurotraum a, 1996, 13(5): 245-254.
9Hillered L, Perssou L. Parabanic acid for monitoring of oxygen radical activity in the injured human brain. Neuroreport, 1995, 6(13): 1816-1820.
10Hillered L, Valtysson J, Enblad P, et al. Interstitial glycerol as a marker for membrane phospholipid degradation in the acutely injured human brain. J Neurol Neurosurg Psychiatry, 1998, 64(4): 486-491.
